Eurofins Scientific, a provider of bioanalytical testing services, agreed to acquire Beacon Discovery, a preeminent drug discovery and contract research organization. Financial terms were not disclosed. "Beacon Discovery adds the expertise in GPCR targets and drug discovery and development experience that will advance our offering in integrated drug discovery services for our clients. This transaction is another demonstration of Eurofins’ commitment to provide the most comprehensive portfolio of laboratory services in the discovery pharmacology field which enjoys a strong outsourcing growth trend," Gilles Martin, Eurofins CEO.